For further information please contact Silo Wellness Investor Relations at 541-900-5871.
– Investor FAQs –
Take a look at all of Silo’s earned media from Forbes to Bloomberg to The Washington Post. Read about how Silo is advancing both psychedelic revenue and psychedelic healing right now.
Listen to interviews with CEO Douglas K. Gordon about the company vision and the asset portfolio.